These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 18494269)
1. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions]. Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269 [TBL] [Abstract][Full Text] [Related]
2. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067 [TBL] [Abstract][Full Text] [Related]
4. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening]. Xu T; Lu HJ; He YF Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832 [TBL] [Abstract][Full Text] [Related]
6. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Bose S; Evans H; Lantzy L; Scharre K; Youssef E Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions. Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457 [TBL] [Abstract][Full Text] [Related]
8. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia. Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662 [TBL] [Abstract][Full Text] [Related]
9. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining. Negri G; Moretto G; Menia E; Vittadello F; Kasal A; Mian C; Egarter-Vigl E J Clin Pathol; 2006 Aug; 59(8):827-30. PubMed ID: 16467166 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections. Liu H; Shi J; Wilkerson M; Huang Y; Meschter S; Dupree W; Lin F Cancer; 2007 Apr; 111(2):74-82. PubMed ID: 17330305 [TBL] [Abstract][Full Text] [Related]
14. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results. Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990 [TBL] [Abstract][Full Text] [Related]
16. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing. Zhang G; Yang B; Abdul-Karim FW Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189 [TBL] [Abstract][Full Text] [Related]
18. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis. Wei Q; Fu B; Liu J; Xu J; Zhao T Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073 [TBL] [Abstract][Full Text] [Related]
19. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437 [TBL] [Abstract][Full Text] [Related]
20. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Guo M; Hu L; Baliga M; He Z; Hughson MD Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]